{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:23:48Z","timestamp":1794673428673,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0983-z","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T23:12:26Z","timestamp":1435619546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Scabies: an ancient global disease with a need for new therapies"],"prefix":"10.1186","volume":"15","author":[{"given":"Jackson","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg M","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley F","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine F","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya E","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"issue":"3","key":"983_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.clindermatol.2005.11.001","volume":"24","author":"E Orion","year":"2006","unstructured":"Orion E, Marcos B, Davidovici B, Wolf R. Itch and scratch: scabies and pediculosis. Clin Dermatol. 2006;24(3):168\u201375.","journal-title":"Clin Dermatol"},{"key":"983_CR2","unstructured":"The Lancet Global Health Blog: \u201cScabies added to the World Health Organisation list of Neglected Tropical Diseases\u201d. (2014), Available at: http:\/\/globalhealth.thelancet.com\/2014\/07\/07\/scabies-joins-list-whoneglected-tropical-diseases (Last accessed 19 June 2015)."},{"key":"983_CR3","first-page":"5","volume":"2","author":"C Connors","year":"1994","unstructured":"Connors C. Scabies treatment. Northern Territory Disease Control Bulletin. 1994;2:5\u20136.","journal-title":"Northern Territory Disease Control Bulletin"},{"issue":"4","key":"983_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2471\/BLT.07.043034","volume":"86","author":"DB Clucas","year":"2008","unstructured":"Clucas DB, Carville KS, Connors C, Currie BJ, Carapetis JR, Andrews RM. Disease burden and health-care clinic attendances for young children in remote Aboriginal communities of northern Australia. Bull World Health Organ. 2008;86(4):275\u201381.","journal-title":"Bull World Health Organ"},{"issue":"10","key":"983_CR5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/ijd.12101","volume":"52","author":"FE McLean","year":"2013","unstructured":"McLean FE. The elimination of scabies: a task for our generation. Int J Dermatol. 2013;52(10):1215\u201323.","journal-title":"Int J Dermatol"},{"issue":"11","key":"983_CR6","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1371\/journal.pntd.0000554","volume":"3","author":"RM Andrews","year":"2009","unstructured":"Andrews RM, Kearns T, Connors C, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3(11):e554.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"983_CR7","doi-asserted-by":"publisher","first-page":"e1755","DOI":"10.1371\/journal.pntd.0001755","volume":"7","author":"K Kline","year":"2013","unstructured":"Kline K, McCarthy JS, Pearson M, Loukas A, Hotez PJ. Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis. 2013;7(1):e1755.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"983_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/QCO.0b013e328336821b","volume":"23","author":"S Bouvresse","year":"2010","unstructured":"Bouvresse S, Chosidow O. Scabies in healthcare settings. Curr Opin Infect Dis. 2010;23(2):111\u20138.","journal-title":"Curr Opin Infect Dis"},{"key":"983_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0065-308X(04)57005-7","volume":"57","author":"SF Walton","year":"2004","unstructured":"Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol. 2004;57:309\u201376.","journal-title":"Adv Parasitol"},{"key":"983_CR10","doi-asserted-by":"crossref","unstructured":"Jayaraj R, Hales B, Viberg L, Pizzuto S, Holt D, Rolland JM, et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis. 2011;71(4):403\u20137.","DOI":"10.1016\/j.diagmicrobio.2011.09.007"},{"key":"983_CR11","first-page":"CD000320","volume":"3","author":"M Strong","year":"2007","unstructured":"Strong M, Johnstone P. Interventions for treating scabies (Review). Cochrane Database Syst Rev. 2007;3:CD000320.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"983_CR12","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1001\/archderm.138.12.1618","volume":"138","author":"N Haas","year":"2002","unstructured":"Haas N, Lindemann U, Frank K, Sterry W, Lademann J, Katzung W. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol. 2002;138(1):1618\u20139.","journal-title":"Arch Dermatol"},{"key":"983_CR13","first-page":"CD009943","volume":"2","author":"D FitzGerald","year":"2014","unstructured":"FitzGerald D, Grainger RJ, Reid A. Interventions for preventing the spread of infestation in close contacts of people with scabies. Cochrane Database Syst Rev. 2014;2:CD009943.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"983_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00128071-200405010-00005","volume":"5","author":"N Scheinfeld","year":"2004","unstructured":"Scheinfeld N. Controlling scabies in institutional settings. Am J Clin Dermatol. 2004;5(1):31\u20137.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"983_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-4362.2000.00990.x","volume":"39","author":"U Paasch","year":"2000","unstructured":"Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol. 2000;39(6):463\u201370.","journal-title":"Int J Dermatol"},{"issue":"9","key":"983_CR16","first-page":"637","volume":"10","author":"J Stoevesandt","year":"2012","unstructured":"Stoevesandt J, Carl\u00e9 L, Leverkus M, Hamm H. Control of large institutional scabies outbreaks. J Dtsch Dermatol Ges. 2012;10(9):637\u201347.","journal-title":"J Dtsch Dermatol Ges"},{"key":"983_CR17","first-page":"233","volume":"65","author":"CG Burkhart","year":"2000","unstructured":"Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis. 2000;65:233\u201340.","journal-title":"Cutis"},{"issue":"16","key":"983_CR18","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMcp052784","volume":"354","author":"O Chosidow","year":"2006","unstructured":"Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354(16):1718\u201327.","journal-title":"N Engl J Med"},{"issue":"8","key":"983_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMct0910329","volume":"362","author":"BJ Currie","year":"2010","unstructured":"Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010;362(8):717\u201325.","journal-title":"N Engl J Med"},{"issue":"4","key":"983_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","volume":"18","author":"RJ Hay","year":"2012","unstructured":"Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world-its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313\u201323.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"983_CR21","first-page":"19","volume":"49","author":"DJ Kemp","year":"2002","unstructured":"Kemp DJ, Walton SF, Harumal P, Currie BJ. The Scourge of Scabies. Biologist. 2002;49(1):19\u201324.","journal-title":"Biologist"},{"issue":"4","key":"983_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1529-8019.2009.01243.x","volume":"22","author":"MI Hicks","year":"2009","unstructured":"Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009;22(4):279\u201392.","journal-title":"Dermatol Ther"},{"issue":"12","key":"983_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1473-3099(06)70654-5","volume":"6","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6(12):769\u201379.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"983_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1346-8138.2011.01481.x","volume":"39","author":"M Goldust","year":"2012","unstructured":"Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5\u00a0% versus ivermectin. J Dermatol. 2012;39(6):545\u20137.","journal-title":"J Dermatol"},{"issue":"2","key":"983_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","volume":"42","author":"V Usha","year":"2000","unstructured":"Usha V, Gopalakrishnan NT. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42(2):236\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"983_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1756-3305-6-106","volume":"6","author":"D Engelman","year":"2013","unstructured":"Engelman D, Martin DL, Hay RJ, et al. Opportunities to investigate the effects of ivermectin mass drug administration on scabies. Parasit Vectors. 2013;6:106.","journal-title":"Parasit Vectors"},{"issue":"6","key":"983_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/ijd.12353","volume":"53","author":"K Haar","year":"2014","unstructured":"Haar K, Romani L, Filimone R, et al. Scabies community prevalence and mass drug administration in two Fijian villages. Int J Dermatol. 2014;53(6):739\u201345.","journal-title":"Int J Dermatol"},{"issue":"1","key":"983_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2014.03.944","volume":"21","author":"T Kearns","year":"2014","unstructured":"Kearns T, Andrews R, Speare R, et al. Prevalence of scabies and strongyloidiasis before and after MDA in a remote Aboriginal community in Northern Territory, Australia. Int J Infect Dis. 2014;21(1):252.","journal-title":"Int J Infect Dis"},{"key":"983_CR29","unstructured":"Therapeutic Goods Administration (TGA): \u201cAustralian Public Assessment Report for Ivermectin (Stromectol\u00ae)\u201d. 2013, Available at: http:\/\/www.tga.gov.au\/auspar\/auspar-ivermectin (Last accessed 19 June 2015)."},{"key":"983_CR30","doi-asserted-by":"crossref","unstructured":"Australian Prescriber: \u201cNew drugs- Ivermectin\u201d. 1997, Available at http:\/\/www.australianprescriber.com\/magazine\/20\/3\/77\/9\/new-drugs\/149\/ivermectin (Last accessed 19 June 2015).","DOI":"10.18773\/austprescr.1997.066"},{"key":"983_CR31","unstructured":"NPS MedicineWise: \u201cIvermectin (Stromectol) for scabies. NPS Medicine Update\u201d. 2014. Available at: http:\/\/www.nps.org.au\/publications\/consumer\/medicine-update\/2014\/ivermectin-stromectol-for-scabies (Last accessed 24 March 2015)."},{"issue":"9412","key":"983_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(04)15738-3","volume":"363","author":"J Heukelbach","year":"2004","unstructured":"Heukelbach J, Feldmeier H. Ectoparasites-the underestimated realm. Lancet. 2004;363(9412):889\u201391.","journal-title":"Lancet"},{"issue":"1","key":"983_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/17460913.3.1.57","volume":"3","author":"KE Mounsey","year":"2008","unstructured":"Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol. 2008;3(1):57\u201366.","journal-title":"Future Microbiol"},{"issue":"7","key":"983_CR34","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","volume":"145","author":"KE Mounsey","year":"2009","unstructured":"Mounsey KE, Holt DC, McCarthy JS, Currie BJ, Walton SF. Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch Dermatol. 2009;145(7):840\u20131.","journal-title":"Arch Dermatol"},{"issue":"6","key":"983_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1365-3164.2010.00895.x","volume":"21","author":"Y Terada","year":"2010","unstructured":"Terada Y, Murayama N, Ikemura H, Morita T, Nagata M. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Vet Dermatol. 2010;21(6):608\u201312.","journal-title":"Vet Dermatol"},{"issue":"1","key":"983_CR36","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1086\/421776","volume":"39","author":"BJ Currie","year":"2004","unstructured":"Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis. 2004;39(1):e8\u201312.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"983_CR37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4269\/ajtmh.2006.74.649","volume":"74","author":"C Pasay","year":"2006","unstructured":"Pasay C, Walton S, Fischer K, Holt D, McCarthy J. PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). AmJTrop Med Hyg. 2006;74(4):649\u201357.","journal-title":"AmJTrop Med Hyg"},{"issue":"960","key":"983_CR38","first-page":"317","volume":"106","author":"MR Leibowitz","year":"1993","unstructured":"Leibowitz MR. Failure of scabies treatment. N Z Med J. 1993;106(960):317\u20138.","journal-title":"N Z Med J"},{"issue":"1","key":"983_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2915.2008.00716.x","volume":"22","author":"C Pasay","year":"2008","unstructured":"Pasay C, Arlian L, Morgan M, et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol. 2008;22(1):82\u20138.","journal-title":"Med Vet Entomol"},{"issue":"12","key":"983_CR40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.5694\/j.1326-5377.1994.tb125968.x","volume":"160","author":"J Fraser","year":"1994","unstructured":"Fraser J. Permethrin: a Top End viewpoint and experience. Med J Aust. 1994;160(12):806.","journal-title":"Med J Aust"},{"issue":"48","key":"983_CR41","first-page":"19052","volume":"13","author":"JA Hoek van den","year":"2008","unstructured":"van den Hoek JA, van de Weerd JA, Baayen TD, et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Euro Surveillance. 2008;13(48):19052.","journal-title":"Euro Surveillance"},{"issue":"6","key":"983_CR42","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2471\/BLT.08.052308","volume":"87","author":"F Ly","year":"2009","unstructured":"Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahe A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ. 2009;87(6):424\u201330.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"983_CR43","first-page":"87","volume":"21","author":"SDA Rizvi","year":"2011","unstructured":"Rizvi SDA, Iftikhar N, Batool F. Effectiveness of oral ivermectin for eradicating infesting mites in patients of scabies. J Pak Assoc Dermatol. 2011;21(2):87\u201392.","journal-title":"J Pak Assoc Dermatol"},{"issue":"1","key":"983_CR44","doi-asserted-by":"publisher","first-page":"e15990","DOI":"10.1371\/journal.pone.0015990","volume":"6","author":"SJ Gilmore","year":"2011","unstructured":"Gilmore SJ. Control strategies for endemic childhood scabies. PLoS ONE. 2011;6(1):e15990.","journal-title":"PLoS ONE"},{"issue":"2 Pt 1","key":"983_CR45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0190-9622(84)70157-5","volume":"11","author":"SA Moberg","year":"1984","unstructured":"Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol. 1984;11(2 Pt 1):242\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"6 Pt 1","key":"983_CR46","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0190-9622(90)70346-J","volume":"23","author":"D Yonkosky","year":"1990","unstructured":"Yonkosky D, Ladia L, Gackenheimer L, Schultz MW. Scabies in nursing homes: an eradication program with permethrin 5\u00a0% cream. J Am Acad Dermatol. 1990;23(6 Pt 1):1133\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"983_CR47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/004947550103100105","volume":"31","author":"EN Nnoruka","year":"2001","unstructured":"Nnoruka EN, Agu CE. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Dr. 2001;31(1):15\u20138.","journal-title":"Trop Dr"},{"issue":"1","key":"983_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0035-9203(00)90454-1","volume":"94","author":"SF Walton","year":"2000","unstructured":"Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg. 2000;94(1):92\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"983_CR49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.29309\/TPMJ\/2012.19.01.1945","volume":"19","author":"M Saqib","year":"2012","unstructured":"Saqib M, Afridi IU, Ali A, Jahangir M. Scabies; Safety of Permethrin and ivermectin. Professional Med J. 2012;19(1):86.","journal-title":"Professional Med J"},{"issue":"3","key":"983_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1201-9712(98)90118-7","volume":"2","author":"SE Huffam","year":"1998","unstructured":"Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis. 1998;2(3):152\u20134.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"983_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/archderm.1979.04010010075035","volume":"115","author":"RJ Coskey","year":"1979","unstructured":"Coskey RJ. Scabies-resistance to treatment with crotamiton. Arch Dermatol. 1979;115(1):109.","journal-title":"Arch Dermatol"},{"issue":"4","key":"983_CR52","first-page":"331","volume":"44","author":"P Glaziou","year":"1993","unstructured":"Glaziou P, Cartel J, Alzieu P, Briot C, Moulia-Pelat J, Martin P. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol. 1993;44(4):331\u20132.","journal-title":"Trop Med Parasitol"},{"issue":"4","key":"983_CR53","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1440-1754.2002.00015.x","volume":"38","author":"P Brooks","year":"2002","unstructured":"Brooks P, Grace R. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health. 2002;38(4):401\u20134.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"983_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1272\/jnms.81.157","volume":"81","author":"K Fujimoto","year":"2014","unstructured":"Fujimoto K, Kawasaki Y, Morimoto K, Kikuchi I, Kawana S. Treatment for crusted scabies: limitations and side effects of treatment with ivermectin. J Nippon Med Sch. 2014;81(3):157\u201363.","journal-title":"J Nippon Med Sch"},{"issue":"8","key":"983_CR55","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2165\/00003495-200161080-00004","volume":"61","author":"TC Roos","year":"2001","unstructured":"Roos TC, Roos S, Merk HF, Bickers DR. Pharmacotherapy of ectoparasitic infections. Drugs. 2001;61(8):1067\u201388.","journal-title":"Drugs"},{"key":"983_CR56","first-page":"CD000320","volume":"3","author":"G Walker","year":"2000","unstructured":"Walker G, Johnstone P. Interventions for treating scabies (Cochrane Review). Cochrane Database Syst Rev. 2000;3:CD000320.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"983_CR57","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1592\/phco.25.3.448.61596","volume":"25","author":"CI Coleman","year":"2005","unstructured":"Coleman CI, Gillespie EL, White CM. Probable topical permethrin\u2010induced neck dystonia. Pharmacotherapy. 2005;25(3):448\u201350.","journal-title":"Pharmacotherapy"},{"key":"983_CR58","doi-asserted-by":"crossref","unstructured":"Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H, et al. Comparative study of 5\u00a0% permethrin cream and 1\u00a0% lindane lotion for the treatment of scabies. Arch Dermatol. 1990;126(2):167\u201370.","DOI":"10.1001\/archderm.1990.01670260037006"},{"key":"983_CR59","first-page":"S531","volume":"86","author":"S Singalavanija","year":"2003","unstructured":"Singalavanija S, Limpongsanurak W, Soponsakunkul S. A comparative study between 10 % sulfur ointment and 0.3 % gamma benzene hexachloride gel in the treatment of scabies in children. J Med Assoc Thail. 2003;86:S531\u20136.","journal-title":"J Med Assoc Thail"},{"issue":"951","key":"983_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/pgmj.2003.018390","volume":"81","author":"K Karthikeyan","year":"2005","unstructured":"Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J. 2005;81(951):7\u201311.","journal-title":"Postgrad Med J"},{"key":"983_CR61","doi-asserted-by":"crossref","unstructured":"Chouela EN, Abeldano AM, Pellerano G, La Forgia M, Papale RM, Garsd A, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol. 1999;135(6):651\u20135.","DOI":"10.1001\/archderm.135.6.651"},{"issue":"2","key":"983_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00001432-200204000-00004","volume":"15","author":"P Giudice del","year":"2002","unstructured":"del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis. 2002;15(2):123\u20136.","journal-title":"Curr Opin Infect Dis"},{"issue":"9059","key":"983_CR63","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0140-6736(05)63020-6","volume":"349","author":"R Barkwell","year":"1997","unstructured":"Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet. 1997;349(9059):1144\u20135.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0983-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0983-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:22:45Z","timestamp":1717960965000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0983-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0983-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]},"article-number":"250"}}